Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a pilot study to determine the safety and efficacy of orbital injections of LIPO-102.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Neothetics, Inc

Criteria

Inclusion Criteria:

• Male or Non pregnant female

• Symptomatic exophthalmos

• Inactive Thyroid Eye Disease

• Signed informed consent

Exclusion Criteria:

• Known hypersensitivity to study drugs

• Treatment with an investigational agent within 30 days of first dose

• History of Thyroid Eye Disease less than 6 months

• Previous decompression surgery

• Glaucoma